Navigation Links
MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results
Date:3/2/2010

2009 and 2010 Year-to-Date Accomplishments and Upcoming Milestones

LEVADEX™ (formerly known as MAP0004)

  • Met all four primary endpoints in the efficacy portion of FREEDOM-301, the first Phase 3 clinical trial of LEVADEX for the potential acute treatment of migraine.  Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours.
  • Completed a planned six month interim safety review of the open-label, long-term safety extension of FREEDOM-301, with no drug-related serious adverse events reported.  The trial is continuing as planned.
  • Received notification from the U.S. Food and Drug Administration that a second pivotal efficacy study is not required for the LEVADEX new drug application (NDA) submission.   The remaining clinical trials needed for NDA submission include the ongoing open-label, long-term safety extension trial, a pharmacokinetics (PK) trial and a pharmacodynamics (PD) trial. The company anticipates that patients in these trials will complete treatment in 2010.
  • Initiated the PK trial in smokers and non-smokers.
  • Anticipate initiating the PD trial in the first half of 2010.
  • Presented additional analysis of FREEDOM-301 at the 14th Congress of the International Headache Society showing the potential of LEVADEX to effectively treat acute migraine as well as a broad spectr
    '/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
2. DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Call
3. Thomas Pharmaceuticals, Ltd to Merge with Global Medical Equipment of AZ
4. Abbott Completes Acquisition of Solvay Pharmaceuticals
5. Biostar Pharmaceuticals, Inc. Announces Change of Auditor
6. Lotus Pharmaceuticals Announces Key Changes
7. Genetix Pharmaceuticals' Adrenoleukodystrophy (ALD) Product Recognized As One of Science Magazine's Top 10 Scientific Breakthroughs of 2009
8. Hospira to Acquire Orchids Generic Injectable Pharmaceuticals Business
9. Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
10. PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings
11. Onyx Pharmaceuticals Announces December 2009 Investor Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... the adage that encourages people to keep their "eyes ... comes to exercise. When walking, staying focused on a ... appear shorter and help people walk there faster, psychology ... to walking while looking around the environment naturally, offers ... , "People are less interested in exercise if physical ...
(Date:10/1/2014)... October 01, 2014 Marriagelifeinsurance.com has ... life insurance for retired couples. , Senior citizens ... financial security for their loved ones. A joint policy ... insured persons pass away. , Life insurance can ... life insurance can even be purchased online, as the ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... 2014 First Warning Systems, a pioneer ... changes throughout the body, announced the company is changing ... the company’s breadth of upcoming product releases. The initial ... technology. , “Our initial focus will be an ‘Internet ... abnormal circadian cellular changes over time,” said Rob Royea, ...
(Date:10/1/2014)... ATLANTA (PRWEB) October 01, 2014 ... executive networking and relationship-marketing firm, announced today ... Security Executive® and Project of the Year ... decision makers representing organizations in financial services, ... include large-scale technology endeavors that address key ...
Breaking Medicine News(10 mins):Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7
... gathering,June 28th to kick off an unusual bus tour. ... her family and friends, and the,VoteHealthcare.org Bandwagon Tour. They,re ... about America,s health care system., Kathie is an ... in,our health care system the hard way. First, her ...
... with Patient Outcome in Neuroblastoma , Expression of ... patients whose tumors lacked CHD5 expression were more likely ... patients whose tumors expressed CHD5. , Neuroblastoma tumors often ... arm of chromosome 1, called 1p36.31. Garrett Brodeur, M.D., ...
... June 24 Blue Cross and Blue Shield,of Illinois ... for,disaster recovery services in areas affected by the current ... hearts go out to the thousands of people who ... by the floods," Paul S. Boulis, BCBSIL,president, said. "Nearly ...
... Inc.,(Nasdaq: SPCHA , SPCHB) is proud to celebrate ... located at 11801 West Olympic Boulevard, Los Angeles,CA 90025. ... A grand opening celebration and sale is scheduled for ... celebrity appearances,sports demonstrations, and free giveaways. On Friday, Saturday ...
... caused some machines to turn off, others to malfunction ... magic little devices that allow you to enter your ... with the operation of critical medical equipment in a ... actual patients, Dutch scientists found that the radio frequency ...
... assistance programs showed that providing prescription drug coverage ... Moreover, needy seniors enrolled in the programs were ... home admissions in half, according to the Brandeis ... implemented state pharmacy assistance programs with joint federal ...
Cached Medicine News:Health News:Mom and Purple Bus Kick-off VoteHealthcare.org Bandwagon Tour 2Health News:Also in the June 24 JNCI 2Health News:Also in the June 24 JNCI 3Health News:Also in the June 24 JNCI 4Health News:Also in the June 24 JNCI 5Health News:Blue Cross and Blue Shield of Illinois Donates $25,000 to American Red Cross for Flood Disaster Recovery 2Health News:Sport Chalet Opens Store in West Los Angeles 2Health News:Radio-Wave Devices May Play Havoc With Medical Equipment 2Health News:Radio-Wave Devices May Play Havoc With Medical Equipment 3Health News:Savings help the medicine go down 2
(Date:9/30/2014)... 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... advance from Hercules Technology Growth Capital, Inc. (NYSE: ... and final advance under the Loan and Security Agreement ... , Alimera Sciences Limited, entered into with Hercules ...
(Date:9/30/2014)... 2014 A study using a relatively new ... look at the composition of carotid artery disease and ... treat the disease, a leading cause of stroke. ... between September 2010 and May 2012, was featured in ... the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... 2014 Valeant Pharmaceuticals International, Inc. (NYSE: ... the company,s Bridgewater, New Jersey ... and Drug Administration (FDA) relating to an inspection in ... Sculptra Aesthetic injectable, which was divested to Galderma S.A. ... of Valeant,s contract manufacturers (rather than Valeant,s own internal ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... 2011 Delcath Systems, Inc. (Nasdaq: DCTH ) ... present at the Lazard Capital Markets, Eighth Annual Healthcare Conference ... New York, NY.  Mr. Hobbs will provide an overview of ... Attendance at this conference is by invitation only.  Delcath ...
... Today, the U.S. Food and Drug Administration (FDA) appealed ... District of Florida ruling in US vs. Franck,s Lab, ... for veterinary patients.  This lawsuit, brought by the Food ... Franck,s Lab in Ocala, Fla., alleged that the use ...
Cached Medicine Technology:Delcath to Present at the Lazard Healthcare Conference on November 15 2Delcath to Present at the Lazard Healthcare Conference on November 15 3International Academy of Compounding Pharmacists (IACP) Responds to FDA's Appeal of the U.S. District Court Ruling on Pharmacy Compounding 2International Academy of Compounding Pharmacists (IACP) Responds to FDA's Appeal of the U.S. District Court Ruling on Pharmacy Compounding 3
80 inch PVC tubing with connectors and 19 gauge straight, beveled cannula. Fits Bausch & Lomb Surgical cassettes. Allows the safe removal of silicone oil in 10 minutes or less. 3/Box...
... gauge, 25 mm cannula with 30 gauge, 4.76 ... mm flattened tip. Cannula is attached to a ... ID x 8 inch long), for use with ... other vitreo-retinal membranes using visco elastic materials. Flattened, ...
20 gauge x 25 mm cannula with 30 degree x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub. 10 per box....
Developed for oculoplastic procedures for corneal and scleral protection. Dimensions enable protector to rest on the sclera and not on the cornea. Easily removed with Bishop-Harmon Forceps. Individua...
Medicine Products: